Natera Says Court Issued Favorable Ruling In False Advertising Trial Against CareDx; Eliminates All Damages
Portfolio Pulse from Benzinga Newsdesk
Natera has received a favorable ruling in a false advertising trial against CareDx, eliminating all damages. The court noted that CareDx showed no evidence of deception or reliance on the advertisements in question. However, the jury's March 2022 verdict that CareDx engaged in false advertising against Natera remains in place.
July 17, 2023 | 8:48 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
CareDx has lost a legal battle against Natera in a false advertising trial, which could negatively impact investor confidence.
The unfavorable ruling for CareDx in the false advertising trial against Natera could be seen as a negative outcome for the company and potentially impact its stock negatively in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Natera has won a legal victory against CareDx in a false advertising trial, which could boost investor confidence.
The favorable ruling for Natera in the false advertising trial against CareDx eliminates all damages, which could be seen as a positive outcome for the company and potentially boost its stock in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100